Full Text View
Tabular View
No Study Results Posted
Related Studies
Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE)
This study is enrolling participants by invitation only.
Study NCT01261234   Information provided by Kobe City General Hospital

First Received on December 11, 2010.   Last Updated on October 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
Cilostazol or Non-Cilostazol
Additional drug interventions recognized in this trial
Cilostazol
Platelet Aggregation Inhibitors
More general drug interventions related to this trial
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Central Nervous System Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase 3 Inhibitors
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Kobe City General Hospital
Chiba University
Nagoya University
Mie University
Wakayama Medical University
Kyoto University
Osaka University
Kobe University
Foundation for Biomedical Research and Innovation
Okayama University
Yamaguchi University Hospital
Fukuoka University
Nagasaki University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services